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Background
Epilepsy is the commonest serious neurological condition with a lifetime cumulative incidence of 2-3%. Although for the majority of people with epilepsy the outlook for seizure control is good, between 20 and 30% will continue to have seizures despite ongoing treatment with antiepileptic drugs (AEDs). Of these, the majority have a symptomatic or cryptogenic localisation-related epilepsy, which for some may be successfully treated with surgical resection of the focus (epilepsy surgery). The prime aim of epilepsy surgery is to remove the seizure focus and hence bring about seizure freedom without causing other disability.
Neuroimaging technologies can provide information about (1) structural abnormalities, hence information about the underlying aetiology of seizures, which in turn will suggest a potential focus, and (2) functional abnormalities (metabolism and/or blood flow) and hence the likely focus of seizures. If effective, these technologies could have a number of potential advantages. First, these tests are non-invasive and for certain patients the need for, and risk of, invasive seizure monitoring could be avoided. Second, they may influence the outcome of epilepsy surgery by influencing patient selection and the procedure undertaken. Third, where imaging results predict the outcome of surgery, patients could be better informed of the likely outcome of surgery.
Objectives
To review the following: 1. The effectiveness and/or accuracy of different methods of imaging the cerebral cortex to visualise the seizure focus in people with refractory epilepsy being considered for surgery. 2. The ability of different neuroimaging techniques to predict patient outcomes following surgery. 3. The effectiveness of imaging in the following subgroups: (a) People for whom a structural abnormality has been previously identified by other neuroimaging techniques.
(b) People for whom no structural abnormality has been previously identified by other neuroimaging techniques. (c) People for whom surface or invasive EEG recording has isolated a seizure focus. (d) People for whom surface or invasive EEG recording has failed to isolate a seizure focus. 4. The cost-effectiveness of imaging the cerebral cortex to visualise the seizure focus in people with refractory epilepsy being considered for surgery.
Methods
A systematic review was undertaken according to published guidelines.
Data sources
Studies were identified through searches of electronic databases, Internet searches, handsearching, scanning reference lists of included papers and consultation with experts in the field.
Study selection
Two reviewers screened titles and abstracts for relevance. Full papers of potentially relevant studies were obtained and assessed for inclusion by one reviewer and checked by a second. Published and unpublished studies in any language were eligible for inclusion.
Data extraction
Data extraction and quality assessment were performed by one reviewer and checked by a second.
Data synthesis
For the diagnostic accuracy studies, results were analysed according to the imaging test evaluated. For each study the proportion of patients who were correctly localised, not localised, partially localised or incorrectly localised by the index test was calculated. Heterogeneity of these proportions was investigated using the 2 or Q statistic and through visual examination of forest plots of study results. Owing to the significant heterogeneity present between studies, statistical pooling was not performed. Instead, a narrative synthesis of results is presented.
Executive summary: Neuroimaging assessments used to visualise seizure focus in refractory epilepsy
Executive summary ᭤ For studies that used multivariate analysis to look at the association of neuroimaging findings and outcome following surgery, all factors considered in the analyses, whether related to the findings of neuroimaging assessments or not, were presented, whether statistically significant or not. The studies were grouped according to the neuroimaging technique investigated and the findings of the studies were discussed with reference to possible sources of heterogeneity between studies.
Sensitivity analyses were performed to investigate the usefulness of carrying out extensive literature searches and including studies published in languages other than English.
Results
No randomised controlled trials (RCTs) were identified, with the majority of studies being diagnostic accuracy studies, evaluating the diagnostic accuracy of various imaging techniques in the localisation of epileptic seizure foci.
Studies were heterogeneous with regard to study design, population characteristics, index test and characteristics, outcome measurements and reference standards. In addition, in the majority of studies, the data had been collected retrospectively or it was not reported whether data collection was prospective. The studies were generally of poor quality, largely owing to the inappropriate populations included in the studies. Only 4% of studies included an appropriate patient spectrum, defined as an unselected group of patients with refractory epilepsy being considered for surgery, prospectively enrolled in the study. The reference standards used varied, and included ictal EEG, a combination of tests, site of eventual surgery, magnetic resonance imaging (MRI), interictal EEG and a combination of ictal and interictal EEG.
The included studies investigated the following imaging techniques: single photon emission computed tomography (SPECT) (39 studies, 68 evaluations); MRI (30 studies, 40 evaluations); position emission tomography (PET) (18 studies, 25 evaluations); subtraction ictal single photon emission computed tomography co-registered to magnetic resonance imaging (SISCOM) (seven studies, 11 evaluations); magnetic resonance spectrosopy (MRS) (six studies); computed tomography (CT) (five studies); near-infrared spectroscopy (NIRS) (one study); combinations of more than one test (three studies). We found no studies evaluating functional magnetic resonance imaging (fMRI) or diffusion tensor imaging.
There was significant heterogeneity ( p < 0.05) between studies for all imaging techniques for at least one of the localisation categories (proportions of patients who had a seizure focus correctly localised, not localised, partially localised and incorrectly localised). Statistical pooling was therefore not undertaken. It was difficult to draw any overall conclusions regarding the accuracy of any imaging technique owing to the differences between studies. Possible explanations for the heterogeneity of localisation categories between studies of the various imaging techniques include differing study designs, population characteristics, index test characteristics and reference standards.
One of the review objectives was to look at the accuracy of neuroimaging techniques to identify the seizure focus in the following four subgroups: people for whom a structural abnormality has/has not been previously identified by other neuroimaging techniques, and people for whom surface or invasive EEG recording has/has not isolated a seizure focus. These subgroups were considered as possible sources of heterogeneity but did not appear to account for any of the differences between studies for any of the imaging techniques evaluated.
Test performance was more promising in studies restricted to patients with temporal lobe epilepsy.
Ictal SPECT generally had more correctly localising and fewer non-localising scans than other techniques evaluated, with 70-100% correctly localising scans and 0-7% incorrectly localising scans in patients with temporal lobe epilepsy. Results for CT and interictal SPECT suggest that these tests are relatively poor at localising the seizure focus. Results for volumetric MRI and PET appear promising, but have been assessed in fewer studies than ictal SPECT. SISCOM and MRS have been assessed in fewer studies, but the results are less promising than those for ictal SPECT. T2 relaxometry was reported in only one small study, with inconclusive results.
A total of 32 studies (83 evaluations) provided data on the association of a localised scan with outcome following surgery. For 15 studies, it was not possible to calculate a relative risk (RR) and these were not included in the analysis. None of the studies included had an appropriate patient spectrum. The majority (24/33) of evaluations suggested that patients with a correctly or partially localised scan had a better outcome following surgery than those with an incorrectly localised or non-localised scan. However, only 2006; Vol. 10: No. 4 
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(Executive summary)
᭤ three studies showed a significant association between having a localised scan and outcome following surgery, two evaluating routine MRI [RR 2.74, 95% confidence interval (CI) 1.32 to 5.67; RR 1.28, 95% CI: 1.00 to 1.63) and the other SISCOM (RR 2.12, 95% CI: 1.01 to 4.44). Both found that patients with a localised scan had a significantly better outcome following surgery than those with a non-localised or incorrectly localised scan.
Nine studies used multivariate analysis to investigate the association of various imaging techniques with the outcome following surgery. The imaging techniques evaluated included MRI (seven studies), MRS and volumetric MRI (one study), PET (three studies), SPECT (one study) and SISCOM (three studies). There was heterogeneity between studies of the ability of various imaging techniques to predict outcome. However, there was a trend for positive localisation of abnormalities to be associated with a beneficial outcome.
Conclusions
Owing to the limitations of the included studies, the results of this review do little to inform clinical practice. We are unable to provide evidence for effectiveness or cost-effectiveness of imaging techniques in the work-up for epilepsy surgery. Results of diagnostic accuracy studies are confounded by limitations in the reference standard used, and studies are subject to both clinical and statistical heterogeneity as outlined above.
Studies investigating the prognostic importance of imaging results for the outcome following epilepsy surgery suggest that abnormalities on imaging are associated with a better clinical outcome. However, the data do not allow an accurate prediction of patient outcome, possibly owing to small sample sizes, and therefore many studies may lack sufficient power to detect a significant association.
Given the inadequacy of existing data, there is a pressing need for studies investigating the utility of imaging techniques in the work-up for epilepsy surgery. The most reliable research methodology for evaluating the influence of imaging technologies on the outcome for patients being considered for surgery is the RCT. RCTs could examine the influence of single tests or combinations of tests on patient outcome. A study of a single test could evaluate the additional benefit that a particular test offers over other routinely offered tests. For example, in a study evaluating PET, all patients would receive routine tests such as MRI, EEG and Wada tests, with those in the experimental arm also receiving a PET scan. Similarly, studies could include a set of routine tests in both arms with an additional combination of tests being offered in the experimental arm. An alternative approach would be to compare different test combinations in different intervention arms. Health economic data could be collected in parallel, allowing a thorough examination of cost-effectiveness. We suggest that it is important that clinicians, patient groups, policy makers and healthcare/research funders meet and debate the most appropriate way to investigate these technologies.
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NHS R&D HTA Programme T he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.
The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.
